失败模式和效应分析在放疗流程QC中应用进展

doi:10.3760/cma.j.issn.1004-4221.2017.11.025

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (1236 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

随着放疗技术的迅速发展,传统质量管理将从以设备为重心的策略转移到以多人员参与的过程为重心。基于预测性风险评估的失效模式与风险分析方法,近年逐步被应用于放疗的流程质量管理。FMEA方法包含四个主要步骤,依次是流程树梳理、FMEA、差错树分析以及流程质量管理方案设计,具体的方法和结果因各放疗流程的特异性以及参与人员的主观性而有所差异,在其可靠性和可行性方面也进行了相关的验证和考虑。本文就FMEA方法在一些放疗中心开展的具体情况作简要综述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	沈九零
	李光俊
	柏森

关键词 ：失败模式和效应分析, 放射疗法, 流程质量控制

Abstract：

With the rapid development of radiotherapy technology, traditional quality management will shift from a device-centric strategy to a process involving multiple people. In recent years, failure mode and effect analysis (FMEA) based on predictive risk assessment has gradually been applied in the quality management of radiotherapy process. The FMEA approach mainly includes four steps:process tree management, FMEA, error tree analysis, and the design of scheme for process quality management. The specific Methods and Resutls are different due to the specificity of radiotherapy process and the subjectivity of participants. Its reliability and feasibility have also been considered and verified. This article reviews the application of FMEA approach in some radiotherapy centers.

Key words： Failure mode and effect analysis Radiotherapy Process quality control

收稿日期: 2016-10-10

通讯作者: 李光俊,Email:gjnick829@sina.com

引用本文:

沈九零,李光俊,柏森. 失败模式和效应分析在放疗流程QC中应用进展[J]. 中华放射肿瘤学杂志, 2017, 26(11): 1354-1358.

Shen Jiuling,Li guangjun,Bai sen. Progress in application of failure mode and effect analysis in the quality control of radiotherapy process[J]. Chinese Journal of Radiation Oncology, 2017, 26(11): 1354-1358.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2017.11.025 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2017/V26/I11/1354

[1] Terezakis SA,Pronovost P,DeWeese T,et al. Systematicprospective safety measures in a large academic radiation oncology department[J].J Comm J Qual Saf,2010(2):291-299.
[2] Williamson JF,Dunscombe PB,Sharpe MB,et al. Quality assurance needs for modern image-based radiotherapy:Recommendations from 2007 inter-organizational symposium on quality assurance of radiation therapy:Challenges of advanced technology[J].Int J Radiat Oncol Biol Phys,2007,71(Suppl 1):S2-S12.DOI:10.1016/j.ijrobp.2007.08.080.
[3] Cunningham J,Coffey M,Kn s T,et al. Radiation Oncology Safety Information System (ROSIS)-Profiles of participants and the first 1074 incident reports[J].Radioth Aoncol,2010,97(3):601-607.DOI:10.1016/j.radonc.2010.10.023.
[4] Yeung TK,Bortolotto K,Cosby S,et al. Quality assurance in radiotherapy:evaluation of errors and incidents recorded over a 10 year period[J].Radioth Aoncol,2005,74(3):283-291.DOI:10.1016/j.radonc.2004.12.003.
[5] Pillay A,Wang J.Modified failure mode and effects analysis using approximate reasoning[J].Reliab Eng System Saf,2003,79(1):69-85.DOI:10.1016/S0951-8320(02)00179-5.
[6] Sawant A,Dieterich S,Svatos M,et al. Failure mode and effectanalysis-based quality assurance for dynamic MLC tracking systems[J].Med Phys,2010,37(12):6466-6479.DOI:10.1118/1.3517837.
[7] Sheridan-Leos N,Schulmeister L,Hartranft S.Failure mode and effect analysis:A technique to prevent chemotherapy errors[J].Clin J Oncol Nurs,2006,10(3):393-398.DOI:10.1188/06.CJON.393-398.
[8] Duwe B,Fuchs BD,Hansen-Flaschen J.Failure mode and effects analysis application to critical care medicine[J].Crit Care Clin,2005,21(1):21-30.DOI:10.1016/j.ccc.2004.07.005.
[9] Saiful Huq M,Fraass AB,Dunscombe BP,et al. A method for evaluating quality assurance needs in radiation therapy[J].Int J Radiat Oncol Biol Phys,2008,71(1):S170-S173.DOI:10.1016/j.ijrobp.2007.06.081.
[10] Ford C,Gaudette R,Myers L,et al. Evaluation of safety in a radiation oncology setting using failure mode and effects analysis[J].Int J Radiat Oncol Biol Phys,2009,74(3):852-858.DOI:10.1016/j.ijrobp.2008.10.038.
[11] Ford CE,Smith K,Terezakis S,et al. A streamlined failure mode and effects analysis[J].Med Phys,2014,41(6 Part 1):617-96.DOI:10.1118/1.4875687.
[12] Broggi S,Cantone MC,Chiara A,et al. Application of failure mode and effects analysis (FMEA) to pretreatment phases in tomotherapy[J].J Appl Clin Med Phys,2013,14(5):265-277.DOI:10.1120/jacmp.v14i5.4329.
[13] Jones TR,Handsfield L,Read WP,et al. Safety and feasibility of STAT RAD:Improvement of a novel rapid tomotherapy-based radiation therapy workflow by failure mode and effects analysis[J].Pract Radiat Oncol,2015,5(2):106-112.DOI:10.1016/j.prro.2014.03.016.
[14] Noel EC,Santanam L,Parik PJ,et al. Process-based quality management for clinical implementation of adaptive radiotherapy[J].Med Phys,2015,41(8):081717.DOI:10.1118/1.4890589.
[15] Veronese I,De Martin E,Martinotti AS,et al. Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT)[J].Radiat Oncol,2015,10:132.DOI:10.1186/s13014-015-0438-0.
[16] Manger PR,Paxton BA,Pawlicki T,et al. Failure mode and effects analysis and fault tree analysis of surface image guided cranial radiosurgery[J].Med Phys,2015,42(5):2449-2461.DOI:10.1118/1.4918319.
[17] Teixeira CF,De Almeida CE,Saiful Huq M.Failure mode and effects analysis based risk profile assessment for stereotactic radiosurgery programs at three cancer centers in Brazil[J].Med Phys,2016,43(1):171-178.DOI:10.1118/1.4938065.
[18] Younge KC,Wang YZ,Thompson J,et al. Practical Implementation of Failure Mode and Effects Analysis for Safety and Efficiency in Stereotactic Radiosurgery[J].Int J Radiat Oncol Biol Phys,2015,91(5):1003-1008.DOI:10.1016/j.ijrobp.2014.12.033.
[19] Masini L,Donis L,Loi G,et al. Application of failure mode and effects analysis to intracranial stereotactic radiation surgery by linear accelerator[J].Pract Radiat Oncol,2014,4(6):392-397.DOI:10.1016/j.prro.2014.01.006.
[20] Zheng YS,Johnson R,Larson G.Minimizing treatment planning errors in proton therapy using failure mode and effects analysis[J].Med Phys,2016,43(6) 2904-2910.DOI:10.1118/1.4948686.
[21] Cantone MC,Ciocca M,Dionisi F,et al. Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy[J].Radiat Oncol,2013,8:127.DOI:10.1186/1748-717X-8-127.
[22] Sayler L,Eldredge-Hindy H,Dinome J,et al. Clinical implementation and failure mode and effects analysis of HDR skin brachytherapy using Valencia and Leipzig surface applicators[J].Brachytherapy,2015,14(2):293-299.DOI:10.1016/j.brachy.2014.11.007.
[23] Mayadev J,Dieterich S,Harse R,et al. A failure modes and effects analysis study for gynecologic high-dose-rate brachytherapy[J].Brachytherapy,2015,14(6):866-875.DOI:10.1016/j.brachy.2015.06.007.
[24] López-Tarjuelo J,Bouché-Babiloni A,Santos-Serra A,et al. Failure mode and effect analysis oriented to risk-reduction interventions in intraoperative electron radiation therapy:The specific impact of patient transportation,automation,and treatment planning availability[J].Radioth Oncol,2014,113(2):283-289.DOI:10.1016/j.radonc.2014.11.012.
[25] Ciocca M,Cantone MC,Veronese I,et al. Application of failure mode and effects analysis to intraoperative radiation therapy using mobile electron linear accelerators[J].Int J Radiat Oncol Biol Phys,2012,82(2):e305-e311.DOI:10.1016/j.ijrobp.2011.05.010.
[26] Huq MS,Fraass BA,Dunscombe PB,et al. The report of Task Group 100 of the AAPM:Application of risk analysis methods to radiation therapy quality management[J].Med Phys,2016,43(7):4209-4262.DOI:10.1118/1.4947547.
[27] Yang F,Cao N,Young L,et al. Validating FMEA output against incident learning data:A study in stereotactic body radiation therapy[J].Med Phys,2015,42(6 Part 1):2777-2785.DOI:10.1118/1.4919440.
[28] Wilkinson DA,Kolar MD.Failure modes and effects analysis applied to high-dose-rate brachytherapy treatment planning[J].Brachytherapy,2013,12(4):382-386.DOI:10.1016/j.brachy.2013.03.002.
[29] Perks RJ,Stanic S,Stern LR,et al. Failure Mode and Effect Analysis for Delivery of Lung Stereotactic Body Radiation Therapy[J].Int J Radiat Oncol Biol Phys,2012,83(4):1324-1329.DOI:10.1016/j.ijrobp.2011.09.019.
[30] Institute for Safe Medical Practices (ISMP).Medication error prevention “toolbox”[R].Medication Safety Alert,1999.